Vir Biotechnology (VIR) Revenue (2018 - 2026)

Vir Biotechnology has disclosed Revenue across 9 years of filings, most recently posting $29000.0 for Q1 2026.

• Revenue for Q1 2026 came in at $29000.0, down 99.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $65.6 million (up 214.24% YoY), and the FY2025 annual result was $68.6 million, down 7.61% from the prior year.
• Revenue came in at $29000.0 for Q1 2026 at Vir Biotechnology, down from $64.1 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $1.2 billion in Q1 2022 to a low of $29000.0 in Q1 2026.
• The 5-year median for Revenue is $12.4 million (2024), against an average of $113.0 million.
• Across the five-year window, Revenue jumped 62271.41% in 2022 and slumped 99.3% in 2023, its largest moves.
• Vir Biotechnology's Revenue stood at $49.4 million in 2022, then plunged by 66.03% to $16.8 million in 2023, then decreased by 26.29% to $12.4 million in 2024, then soared by 417.78% to $64.1 million in 2025, then sank by 99.95% to $29000.0 in 2026.
• The last three Revenue figures came in at $29000.0 (Q1 2026), $64.1 million (Q4 2025), and $240000.0 (Q3 2025), per Business Quant data.